
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $503.1M | -- | -- | $2.07 | -- |
08/06/2025 | Q2 | $365M | -- | -- | $1.10 | -- |
05/06/2025 | Q1 | $380.3M | $424.5M | $1.31 | $1.18 | $0.14 |
02/04/2025 | Q4 | $510.3M | $555.7M | $2.11 | $2.04 | $0.07 |
11/04/2024 | Q3 | $520.5M | $541.9M | $1.83 | $2.02 | -$0.19 |
08/06/2024 | Q2 | $318.4M | $374M | $0.76 | $0.62 | $0.14 |
05/07/2024 | Q1 | $315.6M | $371.8M | $0.81 | $0.64 | $0.17 |
02/06/2024 | Q4 | $540.1M | $619M | $2.50 | $2.01 | $0.49 |
11/02/2023 | Q3 | $457.5M | $481.1M | $1.34 | $1.54 | -$0.20 |
08/03/2023 | Q2 | $286.9M | $317M | $0.28 | $0.41 | -$0.13 |
05/04/2023 | Q1 | -- | $372.8M | -$0.97 | -- | -- |
02/02/2023 | Q4 | -- | $590.6M | $1.83 | -- | -- |
11/01/2022 | Q3 | -- | $540.6M | $1.52 | -- | -- |
08/02/2022 | Q2 | -- | $393.6M | $0.69 | -- | -- |
05/03/2022 | Q1 | -- | $490M | $1.64 | -- | -- |
01/31/2022 | Q4 | -- | $548.3M | $2.16 | -- | -- |
11/01/2021 | Q3 | -- | $465.9M | $1.43 | -- | -- |
07/28/2021 | Q2 | -- | $277.3M | $0.29 | -- | -- |
04/29/2021 | Q1 | -- | $293.5M | $0.42 | -- | -- |
02/01/2021 | Q4 | -- | $485.8M | $1.91 | -- | -- |
11/02/2020 | Q3 | -- | $347.3M | $0.99 | -- | -- |
08/03/2020 | Q2 | -- | $242.6M | $0.30 | -- | -- |
05/04/2020 | Q1 | -- | $279.3M | $0.17 | -- | -- |
01/29/2020 | Q4 | -- | $374.7M | $1.13 | -- | -- |
10/30/2019 | Q3 | -- | $388.9M | $1.27 | -- | -- |
07/31/2019 | Q2 | -- | $238.3M | $0.08 | -- | -- |
05/01/2019 | Q1 | -- | $240.4M | $0.10 | -- | -- |
01/30/2019 | Q4 | -- | $324.3M | $0.49 | -- | -- |
11/01/2018 | Q3 | -- | $366.3M | $0.93 | -- | -- |
08/01/2018 | Q2 | -- | $254.5M | -$0.07 | -- | -- |
05/02/2018 | Q1 | -- | $303.2M | $0.19 | -- | -- |
02/05/2018 | Q4 | -- | $482.7M | $0.52 | -- | -- |
11/02/2017 | Q3 | -- | $425.5M | $1.10 | -- | -- |
08/02/2017 | Q2 | -- | $320.7M | $0.64 | -- | -- |
05/03/2017 | Q1 | -- | $327.9M | $0.52 | -- | -- |
02/01/2017 | Q4 | -- | $523M | $1.83 | -- | -- |
10/27/2016 | Q3 | -- | $428.6M | $1.30 | -- | -- |
07/27/2016 | Q2 | -- | $259.4M | $0.27 | -- | -- |
04/26/2016 | Q1 | -- | $232M | $0.21 | -- | -- |
01/27/2016 | Q4 | -- | $347.9M | $0.63 | -- | -- |
10/28/2015 | Q3 | -- | $306.8M | $0.53 | -- | -- |
Cirrus Logic reported $424.5M worth of top line sales in its most recent quarter.
Cirrus Logic announced earnings per share of $1.31 which represents a beat of analyst forecast a $1.18 per share.
Cirrus Logic reported $226.7M that represents $4.17 per share over the last quarter.
Cirrus Logic's earnings are forecast to grow from $6.00 per share to $6.97 per share next year representing an increase of 17.2%.
Cirrus Logic's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.